Regulation of NANOG in cancer cells
Citations Over TimeTop 10% of 2015 papers
Abstract
As one of the key pluripotency transcription factors, NANOG plays a critical role in maintaining the self-renewal and pluripotency in normal embryonic stem cells. Recent data indicate that NANOG is expressed in a variety of cancers and its expression correlates with poor survival in cancer patients. Of interest, many studies suggest that NANOG enhances the defined characteristics of cancer stem cells and may thus function as an oncogene to promote carcinogenesis. Therefore, NANOG expression determines the cell fate not only in pluripotent cells but also in cancer cells. Although the regulation of NANOG in normal embryonic stem cells is reasonably well understood, the regulation of NANOG in cancer cells has only emerged recently. The current review provides a most updated summary on how NANOG expression is regulated during tumor development and progression.
Related Papers
- → Regulation of Self-Renewal and Pluripotency by Sox2 in Human Embryonic Stem Cells(2008)305 cited
- → Spheroid body-forming cells in the human gastric cancer cell line MKN-45 possess cancer stem cell properties(2012)119 cited
- → The Death-inducer Obliterator 1 (Dido1) Gene Regulates Embryonic Stem Cell Self-renewal(2013)55 cited
- → Dynamics of The Expression of Pluripotency and Lineage Specific Genes in The Pre and Peri-Implantation Goat Embryo.(2019)8 cited
- → Effects of leukemia inhibitory factor on transcript expression of pluripotent genes in bovine embryonic stem like cells(2014)